Wei Ooi

1000 total citations
22 papers, 758 citations indexed

About

Wei Ooi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Wei Ooi has authored 22 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Wei Ooi's work include Bone health and treatments (8 papers), Cancer-related cognitive impairment studies (5 papers) and Cancer Diagnosis and Treatment (5 papers). Wei Ooi is often cited by papers focused on Bone health and treatments (8 papers), Cancer-related cognitive impairment studies (5 papers) and Cancer Diagnosis and Treatment (5 papers). Wei Ooi collaborates with scholars based in Canada, Ireland and Singapore. Wei Ooi's co-authors include Mark Clemons, David E.C. Cole, George Dranitsaris, Christine Simmons, Yoon Sim Yap, Preetha Madhukumar, Alexandre Chan, Wei Sean Yong, Wen Yee Chay and Gilbert Fan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of Clinical Epidemiology.

In The Last Decade

Wei Ooi

21 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Ooi Canada 10 398 328 136 132 119 22 758
Müge Akmansu Türkiye 15 179 0.4× 237 0.7× 95 0.7× 108 0.8× 160 1.3× 66 733
San‐Chi Chen Taiwan 16 260 0.7× 167 0.5× 30 0.2× 128 1.0× 118 1.0× 53 785
Valentina Elisabetta Bounous Italy 18 278 0.7× 160 0.5× 66 0.5× 55 0.4× 123 1.0× 43 858
Sezer Sağlam Türkiye 18 438 1.1× 158 0.5× 29 0.2× 70 0.5× 340 2.9× 78 826
Cem Uzal Türkiye 16 203 0.5× 165 0.5× 29 0.2× 108 0.8× 124 1.0× 46 664
Miia Suuriniemi United States 15 196 0.5× 162 0.5× 55 0.4× 236 1.8× 83 0.7× 18 847
Konstantinos Papadimitriou Greece 12 340 0.9× 92 0.3× 19 0.1× 150 1.1× 78 0.7× 51 724
Daniela Rizzo Italy 17 102 0.3× 130 0.4× 129 0.9× 182 1.4× 113 0.9× 37 705
Stephanie Hsu United States 10 164 0.4× 110 0.3× 36 0.3× 471 3.6× 117 1.0× 21 909

Countries citing papers authored by Wei Ooi

Since Specialization
Citations

This map shows the geographic impact of Wei Ooi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ooi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ooi more than expected).

Fields of papers citing papers by Wei Ooi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Ooi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ooi. The network helps show where Wei Ooi may publish in the future.

Co-authorship network of co-authors of Wei Ooi

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Ooi. A scholar is included among the top collaborators of Wei Ooi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Ooi. Wei Ooi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheung, Yin Ting, Terence Ng, Han Kiat Ho, et al.. (2015). Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study. Annals of Oncology. 26(7). 1446–1451. 186 indexed citations
2.
Cheung, Yin Ting, Maung Shwe, Yee Pin Tan, et al.. (2014). Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: Cognitive function (FACT-Cog) in breast cancer patients. Journal of Clinical Epidemiology. 67(7). 811–820. 93 indexed citations
3.
Cheung, Yin Ting, Wai Keung Chui, Han Kiat Ho, et al.. (2013). Association of pro-inflammatory biomarkers and post-chemotherapy cognitive changes in Asian breast cancer patients: A prospective cohort study.. Journal of Clinical Oncology. 31(15_suppl). 9506–9506. 1 indexed citations
4.
Ooi, Wei, et al.. (2013). A case of large B-cell intravascular lymphoma in the brain. Surgical Neurology International. 4(1). 99–99. 3 indexed citations
5.
Ng, Terence, Yin Ting Cheung, Han Kiat Ho, et al.. (2013). Plasma vascular endothelial growth factor level and cognitive changes in breast cancer patients.. Journal of Clinical Oncology. 31(15_suppl). e20566–e20566. 1 indexed citations
6.
Chan, Alexandre, Yee Pin Tan, Wei Sean Yong, et al.. (2013). Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: Cognitive function (FACT-Cog) in breast cancer patients.. Journal of Clinical Oncology. 31(15_suppl). 6589–6589. 1 indexed citations
7.
Tai, Wai Meng David, Wei Ooi, Joanne Ngeow, et al.. (2011). A phase I study of dovitinib in combination with capecitabine and oxaliplatin in upfront treatment of advanced colorectal and gastric cancer with a dose expansion cohort in advanced gastric cancer.. Journal of Clinical Oncology. 29(15_suppl). TPS174–TPS174. 1 indexed citations
8.
Walsh, Naomi, Susan Kennedy, A. Larkin, et al.. (2010). Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis. British Journal of Cancer. 102(7). 1157–1162. 32 indexed citations
9.
Walsh, Naomi, Annemarie Larkin, Susan Kennedy, et al.. (2009). Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma. BMC Urology. 9(1). 6–6. 73 indexed citations
10.
Broom, Reuben, Hongyan Du, Mark Clemons, et al.. (2009). Switching Breast Cancer Patients with Progressive Bone Metastases to Third-Generation Bisphosphonates: Measuring Impact Using the Functional Assessment of Cancer Therapy-Bone Pain. Journal of Pain and Symptom Management. 38(2). 244–257. 47 indexed citations
11.
Amir, Eitan, Christine Simmons, Orit Freedman, et al.. (2009). A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases. Cancer. 116(2). 284–291. 55 indexed citations
12.
Amir, Eitan, Wei Ooi, Christine Simmons, et al.. (2008). Discordance between Receptor Status in Primary and Metastatic Breast Cancer: an Exploratory Study of Bone and Bone Marrow Biopsies. Clinical Oncology. 20(10). 763–768. 53 indexed citations
13.
14.
O’Driscoll, Lorraine, Naomi Walsh, A. Larkin, et al.. (2007). MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma.. PubMed. 27(4B). 2115–20. 52 indexed citations
15.
Ooi, Wei, et al.. (2007). Mechanisms of bone metastasis (BM) growth in patients with metastatic breast cancer (MBC): An exploratory study. Journal of Clinical Oncology. 25(18_suppl). 1102–1102. 2 indexed citations
16.
17.
18.
Ooi, Wei & John Crown. (2004). Medical Problems in Patients With Malignancy. Journal of Clinical Oncology. 22(19). 4022–4023. 5 indexed citations
19.
Leary, Meghan, S Roy, Wei Ooi, et al.. (2004). Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer. Journal of Clinical Oncology. 22(14_suppl). 2129–2129. 1 indexed citations
20.
Leary, Meghan, S Roy, Wei Ooi, et al.. (2004). Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer. Journal of Clinical Oncology. 22(14_suppl). 2129–2129. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Müge Akmansu Breakdown of academic impact, for papers by San‐Chi Chen Breakdown of academic impact, for papers by Valentina Elisabetta Bounous Breakdown of academic impact, for papers by Sezer Sağlam Breakdown of academic impact, for papers by Cem Uzal Breakdown of academic impact, for papers by Miia Suuriniemi Breakdown of academic impact, for papers by Konstantinos Papadimitriou Breakdown of academic impact, for papers by Daniela Rizzo Breakdown of academic impact, for papers by Stephanie Hsu
Rankless by CCL
2026